Berne, 100 %
The laboratory of Prof. Christoph Schlapbach (Department of Dermatology, Inselspital Bern, University of Bern) studies how human T helper cells drive inflammatory skin disease and how these mechanisms can be targeted therapeutically, combining human immunology, tissue models, multi-omics, and translational research.
In psoriasis, tissue-resident memory TH17 cells persist in resolved skin and drive relapse. We recently showed that activating the aryl hydrocarbon receptor (AHR) metabolically reprograms human memory T cells and selectively restrains TH17 responses. This PhD project will define how metabolic pathways regulate the persistence and pathogenicity of skin-resident memory T cells and explore metabolic reprogramming as a route to durable disease control.
The position is funded by Inselspital Bern and requires admission to the Graduate School for Cellular and Biomedical Sciences (GCB), University of Bern.
The project combines human immunology, transcriptomics, metabolomics, and advanced ex vivo human skin models. State-of-the art experimental approaches include:
The PhD candidate will work in close collaboration with and be supported by senior scientists and clinicians in an interdisciplinary and highly collaborative environment. The position also offers opportunities to supervise Master's students and present research at national and international conferences.
Location Inselspital, Universitätsspital
Organisation
Medical division internal medicine
Area Department of Dermatology
Workload
100 %
Start
Starting 1 November 2026 or by mutual agreement
Reference
19590
Type of Contract
Temporary , Fixed-term for 4 years
Work Location
Inselspital, Universitätsspital Bern
Freiburgstrasse, CH-3010 Bern
Schweiz